What Biotech Founders Should Outsource (and the 3 Things They Never Should)

Every hour a founder-scientist spends on bookkeeping is an hour stolen from the only thing the company actually has: the science. Nobody funded you to reconcile invoices. The science is the asset; everything else is overhead on your attention. The discipline that separates founders who scale from founders who stall is knowing exactly what to keep and what to hand off.

Here is the split.

Keep — the three things only you can do

Capital allocation. Which experiment, which trial, which bet. This is the company. No one can make these calls for you, because they require judgment about the science that only you have.

The story. Nobody can pitch your science but you. Investors fund conviction, and conviction doesn't delegate. The narrative that connects your data to a fundable future is founder work, permanently.

Key people. Who joins, who leads, who leaves. Culture and talent decisions compound, and they can't be outsourced to anyone whose name isn't on the company.

Outsource — everything with a deadline and a template

Bookkeeping, payroll, accruals. A solved problem you're solving badly at 11pm. Hand it to people who do it every day.

Grant applications and R&D tax credits. Specialists recover money you didn't know existed. This is literally free runway — one of the highest-ROI things a research-stage company can outsource.

CRO contract management. The overcharges here are structural, not occasional. It is not unusual for a proper audit to surface six or seven figures of recoverable spend in a single engagement.

FDA submission mechanics. Two months of an expert beats a year of your own learning curve. The regulatory pathway is not where you want to be a beginner.

The data room. Build it once, professionally, before the raise — not in a panic during it. A diligence-ready data room is one of the biggest determinants of how fast and how well a round closes.

The pattern: keep judgment, outsource execution

Your investors can buy execution. They cannot buy your judgment about the science — that is the thing they actually funded. Every hour you spend on templated, deadline-driven work is an hour you are not spending on the irreplaceable part.

Guard your attention like the asset it is.

Frequently asked questions

What should an early-stage biotech founder outsource first?
Bookkeeping and R&D tax credit / grant recovery. The first removes low-value work; the second often pays for itself many times over in recovered runway.

Should a founder-scientist hire a full-time CFO?
Rarely early on. A fractional CFO covers the strategic layer — modeling, fundraising support, board reporting, diligence prep — at a fraction of a $250K–$450K full-time hire, which most research-stage companies can't justify yet.

Why does the data room matter so much before a raise?
Investors read a messy data room as operational risk. Building it professionally before you go to market compresses diligence and protects your terms.

---

Zenith gives life sciences founders an industry-matched fractional CFO and a diligence-ready finance function — so you can keep your attention on the science. Book a Transaction Readiness Audit.